Join Annette Bowyer as She Explores Heparin-Induced Thrombocytopenia!
Sysmex Europe Haemostasis shared on LinkedIn:
”We are delighted to launch Season 2 of our haemostasis webinar series “Haemostasis and Beyond. Meet the Expert”!
Our first session will focus on an important topic:
Heparin-induced thrombocytopenia (HIT) – a severe complication in patients treated with heparins, including unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH). HIT can result in serious thromboembolic events, often associated with considerable morbidity and mortality.
Join Annette Bowyer as she explores:
- What HIT is and how it develops
- Current approaches to diagnosis and management
- The essential role of the HISCL HIT IgG assay kit in supporting patient care
Save the date: 16.10.2025, 11:00 CEST
Link.
Do not miss the opening session of Season 2 – expand your knowledge, meet the experts, and stay at the forefront of haemostasis diagnostics.”
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Jul 3, 2026, 05:55New Evidence Supports Chromogenic Assays After Hemophilia A Gene Therapy – JTH
-
Jul 3, 2026, 05:50Jacopo Parizzi: Roche’s Non-Malignant Hematology Team Is Looking Ahead to 2027
-
Jul 3, 2026, 05:25Brian A Beh: A New Approach from The George Institute for Global Health Could Transform Stroke Care Before Hospital Arrival
-
Jul 3, 2026, 05:22Deirdre Finnigan: New Insights into Red Blood Cell Biomechanics in Cancer-Associated Anemia
-
Jul 3, 2026, 05:15Danielle Boyle: Collaboration Across Borders Is Helping Shape the Future of ITP Care
-
Jul 3, 2026, 05:05Claire McIvor: One Year at the Stroke Association and Grateful for a Workplace That Made It Possible
-
Jul 2, 2026, 23:11Michael Makris: Join The Cancer Associated Thrombosis Workshop at ISTH 2026
-
Jul 2, 2026, 21:54Rob Maloney: Rare Disease Requires Relational Care
-
Jul 2, 2026, 21:53Quintijn Bonnez: How ADAMTS13 Conformation May Predict Early Relapse and Guide Pre-Emptive Therapy